These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26809070)

  • 1. Re: Kryvenko et al.: Prostate-specific Antigen Mass Density - A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution (Urology, 2016;90:141-147).
    Pishgar F
    Urology; 2016 Apr; 90():228-9. PubMed ID: 26809070
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution.
    Kryvenko ON; Diaz M; Matoso A; Kates M; Cohen J; Swanson GP; Epstein JI
    Urology; 2016 Apr; 90():141-7. PubMed ID: 26773349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Comment.
    Benson MC
    Urology; 2016 Apr; 90():147. PubMed ID: 27036684
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply by the Authors.
    Kryvenko ON
    Urology; 2016 Apr; 90():229-30. PubMed ID: 26820119
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between obesity-related plasma hemodilution and the concentration of prostate specific antigen].
    Li F; Yin X; Li D; Yin Z; Qi S; Shi H; Gao J; Zhang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1721-4. PubMed ID: 26714904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Obesity Modify the Ability of Prebiopsy Prostate Specific Antigen to Detect Prostate Cancer on Repeat Biopsy? Results from the REDUCE Study.
    Vidal AC; Howard LE; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
    J Urol; 2015 Jul; 194(1):52-7. PubMed ID: 25661298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
    Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
    Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment from Dr Urakami to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Urakami S
    Int J Urol; 2014 Oct; 21(10):990-1. PubMed ID: 24909066
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.
    Kryvenko ON; Epstein JI; Meier FA; Gupta NS; Menon M; Diaz M
    Am J Clin Pathol; 2015 Aug; 144(2):271-7. PubMed ID: 26185312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment from Dr Simonato and Dr Romagnoli to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Simonato A; Romagnoli A
    Int J Urol; 2014 Oct; 21(10):991. PubMed ID: 24931339
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Al-Azab R, Toi A, Lockwood G, et al. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL (Urology 69:103-107, 2007).
    Stephan C; Jung K; Lein M; Deger S
    Urology; 2008 Oct; 72(4):951. PubMed ID: 18926253
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Kim JH; Doo SW; Yang WJ; Lee KW; Lee CH; Song YS; Jeon YS; Kim ME; Kwon SS
    Int J Urol; 2014 Oct; 21(10):987-90. PubMed ID: 24825391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.
    Zhang J; Ma M; Nan X; Sheng B
    Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Billis et al.: Does the type of prostatic atrophy influence the association of extent of atrophy in needle biopsies and serum prostate-specific antigen levels? (Urology 2009;74:1111-1115).
    Papatsoris A; Albanis S; Deliveliotis C
    Urology; 2010 May; 75(5):1239; author reply 1240. PubMed ID: 20451754
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of body mass index and prostate specific antigen in a population-based study.
    Thompson IM; Leach R; Troyer D; Pollock B; Naylor S; Higgins B
    Urol Oncol; 2004; 22(2):127-31. PubMed ID: 15082010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: The Impact of Obesity on the Predictive Accuracy of PSA in Men Undergoing Prostate Biopsy.
    Kaplan SA
    J Urol; 2015 Aug; 194(2):394-5. PubMed ID: 26195366
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Kim et al.: detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/ml (Urology 2010;76:919-922).
    Shenoy SP; Marla PK; Adappa KK
    Urology; 2011 Apr; 77(4):1013-4; author reply 1014. PubMed ID: 21477737
    [No Abstract]   [Full Text] [Related]  

  • 19. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
    Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
    JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
    Stamatiou K; Alevizos A; Mariolis A; Sofras F
    J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.